GCG and obesity due to melanocortin 4 receptor deficiency: On the other hand, a successful drug Wegovy was FDA-approved in 2021 for treating obesity [148], which is a receptor agonist for glucagon-like peptide 1, another commonly studied hormone for regulation of energy homeostasis.